Prevalence of cardiac arrhythmia in obstructive sleep apnea syndrome

Repetitive transient activation of the parasympathetic and sympathetic systems in obstructive sleep apnea syndrome (OSAS) constitutes the basis for development of cardiac arrhythmias. We aimed to examine the prevalence of arrhythmias in OSAS. Materials and methods: Eighty-eight patients with suspected OSAS were included in the study. Polysomnography was performed overnight in all patients. Patients with apnea-hypopnea index (AHI) < 5 were considered OSAS negative, while patients with AHI >= 5 were OSAS positive. Arrhythmia was defined as sinus bradycardia, sinus tachycardia, > 10/h supraventricular premature beats (SVPBs), > 10/h ventricular premature beats (VEBs), complex VPBs (bigeminal, trigeminal VEB or nonsustained VT), supraventricular tachycardia, ventricular tachycardia, > 2 s sinus arrest, second or third degree atrioventricular block and atrial fibrillation. Results: Mean age was 47.3 ± 10.5 years; 64 were (72.7%) men, and 24 were (27.3%) women; mean body mass index was 31.1 ± 6.1 kg/m2. Twenty-five patients were considered OSAS negative (mean AHI: 2.5 ± 1.2) and 63 patients OSAS positive (mean AHI: 40.3 ± 19.4) according to polysomnography records. Six patients in the OSAS-negative group had arrhythmia, whereas 29 patients in OSAS positive group had arrhythmia and the difference between the groups was statistically significant (P = 0.04). The prevalence of cardiac arrhythmia showed an increase parallel to the increase in AHI index in OSAS positive patients. Conclusion: We demonstrated an increased prevalence of cardiac arrhythmia in OSAS positive patients, parallel to the increase in the severity of OSAS.

Prevalence of cardiac arrhythmia in obstructive sleep apnea syndrome

Repetitive transient activation of the parasympathetic and sympathetic systems in obstructive sleep apnea syndrome (OSAS) constitutes the basis for development of cardiac arrhythmias. We aimed to examine the prevalence of arrhythmias in OSAS. Materials and methods: Eighty-eight patients with suspected OSAS were included in the study. Polysomnography was performed overnight in all patients. Patients with apnea-hypopnea index (AHI) < 5 were considered OSAS negative, while patients with AHI >= 5 were OSAS positive. Arrhythmia was defined as sinus bradycardia, sinus tachycardia, > 10/h supraventricular premature beats (SVPBs), > 10/h ventricular premature beats (VEBs), complex VPBs (bigeminal, trigeminal VEB or nonsustained VT), supraventricular tachycardia, ventricular tachycardia, > 2 s sinus arrest, second or third degree atrioventricular block and atrial fibrillation. Results: Mean age was 47.3 ± 10.5 years; 64 were (72.7%) men, and 24 were (27.3%) women; mean body mass index was 31.1 ± 6.1 kg/m2. Twenty-five patients were considered OSAS negative (mean AHI: 2.5 ± 1.2) and 63 patients OSAS positive (mean AHI: 40.3 ± 19.4) according to polysomnography records. Six patients in the OSAS-negative group had arrhythmia, whereas 29 patients in OSAS positive group had arrhythmia and the difference between the groups was statistically significant (P = 0.04). The prevalence of cardiac arrhythmia showed an increase parallel to the increase in AHI index in OSAS positive patients. Conclusion: We demonstrated an increased prevalence of cardiac arrhythmia in OSAS positive patients, parallel to the increase in the severity of OSAS.

___

  • 1. ASDA-Diagnostic Classification Steering Committee. The International Classification of Sleep Disorders. Diagnostic and Coding Manual, Ed.2, Lawrance, KS: Allen Pres Inc, 1997.
  • 2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-35.
  • 3. Strauss RS, Browner WS. Risk for obstructive sleep apnea. Ann Intern Med 2000; 132: 758-59.
  • 4. Hedner J, Grote L. Cardiovascular consequences of obstructive sleep apnea. Eur Respir Mon 1998; 10: 227-65.
  • 5. Phillips B. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev 2005; 9: 131-140.
  • 6. Paris JM, Somers VK. Obstructive Sleep Apnea and Cardiovascular Disease. Mayo Clin Proc 2004; 79: 1036-46.
  • 7. Roux F, D’Ambrosio CD, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med. 2000; 108: 396- 402.
  • 8. Gula LJ, Krahn AD, Skanes AC, Yee R, Klein GJ. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart. 2004; 90: 347-52.
  • 9. The report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-89.
  • 10. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
  • 11. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A. Cyclic variation of the heart rate in sleep apnea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet 1984; 1: 126-131.
  • 12. Scharf SM. Influence of sleep state and breathing on cardiovascular function. In: Saunders NA, Sullivan CF, editors. Sleep and Breathing. New York: Marcel Decker; 1994. p.221-39.
  • 13. Schneider H, Schaub CD, Andreoni KA, Schwartz AR, Smith PL, Robotham JL, O’Donnell CP. Systemic and pulmonary hemodynamic response to normal and obstructed breathing during sleep. J Appl Physiol 1997; 83: 1671-80.
  • 14. Peter JH, Koehler U, Grote L, Podszus T. Manifestations and consequences of obstructive sleep apnoea. Eur Respir J 1995; 8: 1572-83.
  • 15. Hamilton GS, Solin P, Naughton MT. Obstructive sleep apnoea and cardiovascular disease. Intern Med J. 2004; 34: 420-26. 16. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias: Is there a relationship? Am Rev Respir Dis. 1993; 143: 618-21.
  • 17. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52: 490-94.
  • 18. Roche F, Xuong AN, Court-Fortune I, Costes F, Pichot V, Duverney D, Vergnon JM, Gaspoz JM, Barthélémy JC. Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias and autonomic imbalance. Pacing Clin Electrophysiol 2003; 26: 669-77.
  • 19. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring and sleep apnea. Chest 1994; 106: 466-471.
  • 20. Cortelli P, Parchi P, Storza E, Contin M, Pierangeli G, Barletta G, Lugaresi E. Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnea syndrome. Clin Auton Res 1994; 4: 57-62.
  • 21. Guilleminault C, Simmons FB, Motta J, Cummiskey J, Rosekind M, Schroeder JS, Dement WC. Obstructive sleep apnea syndrome and tracheostomy. Long-term follow-up experience. Arch Intern Med 1981; 141: 985-88.
  • 22. Lown B, Temte JV, Reich P, Gaughan C, Regestein Q, Hal H. Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management. N Engl J Med 1976; 294: 623-29.
  • 23. Grimm W, Hoffmann J, Menz V, Köhler U, Heitmann J, Peter JH, Maisch B. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77: 1310-14.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Effects of aqueous garlic extract on oxidant/antioxidant status in 32D and 32Dp210 cell lines

Nuray VAROL, Erdinç DEVRİM, İlker DURAK, Asuman SUNGUROĞLU, Aslıhan AVCI, İmge B. ERGÜDER, Gaüven Gümüş AKAY, Özkal Pınar BAYDIN

Comparison of in vitro cytotoxicity and genotoxicity of MMA-based polymeric materials and various metallic materials

Nesrin HASIRCI, Bilge Hakan ŞEN, Tuba ENDOĞAN, Gülçe Sultan İZ, Delioğlu Saime İsmet GÜRHAN

The association of TAFI (Thrombin-activatable fibrinolysis inhibitor) with insulin resistance and components of metabolic syndrome in patients with metabolic syndrome

Alev KURAL, Tülay OMMA, Ahmet OMMA, Namık YİĞİT, Hatice SEVAL, Macit KOLDAŞ

The effects of adjuvant therapies for sepsis on hepatic and renal function: a retrospective analysis of 108 ICU patients

Füsun EROĞLU, Şenol GÜLMEN, Ömer Rıdvan TARHAN, Lütfi YAVUZ, Berit Gökçe CEYLAN, Adnan ALACA

Prevalence of Helicobacter pylori infection in healthcare workers

Batool SHARIFI-MOOD, Maliheh METANAT, Shahrokh IZADI

Predisposing factors for serum sodium disturbance in patients with severe traumatic brain injury (SBI)

Azim HONARMAND, Mohammadreza SAFAVI, Daruosh MORADI, Saeid ABRISHAMKAR, Pouria TAVAKOLI

Histomorphometric study on the effect of low dose deltamethrin on the developing cerebellar cortex

Mohd Asnizam ASARI, Mokammad Shukri ABDULLAH, Zul Izhar Mohd ISMAIL

Türkiye’nin Doğu Karadeniz bölgesindeki kırım-kongo kanamalı ateş vakaları: demografik, coğrafik, iklimsel ve klinik özellikler

Gürdal YILMAZ, Kemalettin AYDIN, Rahmet ÇAYLAN, Sucu Nurgün GÜNAYDUN, İftihar KÖKSAL

Vitamin C modulates oxidative stress-induced colitis in rats

Ali UZUNKÖY, Davut MUSA, Abdullah ÖZGÖNÜL, Şehabettin SELEK, Muharrem BİTİREN, Yaşar NAZLIGÜL, Mustafa ZERİN, Ali Ziya KARAKILÇIK

Investigation of the HLA class I antigens in patients with primary spontaneous pneumothorax

Akın Eraslan BALCI, Muharrem ÇAKMAK, Halit ELYAS, Mehmet Oğuzhan ÖZYURTKAN, Önalan Ebru ETEM